HB Estate Developers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 7:37 pm

Quick Insight

HB Estate Developers Ltd, with a current share price of ₹77.7 and a market capitalization of ₹167 Cr., presents a mixed picture in terms of valuation metrics. While the P/E ratio stands at 15.4, indicating a moderate level of earnings multiple, the ROE and ROCE figures at 6.67% and 8.23% respectively suggest room for improvement in capital efficiency. The company's OPM of 39.90% is healthy, reflecting strong operational performance, but the net profit of ₹11 Cr. may raise concerns about bottom-line growth. With a significant promoter holding of 71.98% and a low FII and DII ownership, the stock seems to rely heavily on domestic investor sentiment. The relatively low P/BV ratio of 1.24x indicates a potential undervaluation, while a comfortable ICR of 2.08x provides assurance on debt repayment capabilities. Overall, HB Estate Developers Ltd appears to be a company with sound fundamentals but with opportunities for enhancing profitability and investor diversification.

Competitors of HB Estate Developers Ltd

All Competitor Stocks of HB Estate Developers Ltd

Quarterly Result

Last Updated: May 31, 2025, 5:44 am

Below is a detailed analysis of the quarterly data for HB Estate Developers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 33.23 Cr.. The value appears strong and on an upward trend. It has increased from 31.41 Cr. (Dec 2024) to 33.23 Cr., marking an increase of 1.82 Cr..
• For Expenses, as of Mar 2025, the value is 19.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.65 Cr. (Dec 2024) to 19.97 Cr., marking an increase of 1.32 Cr..
• For Operating Profit, as of Mar 2025, the value is 13.26 Cr.. The value appears strong and on an upward trend. It has increased from 12.76 Cr. (Dec 2024) to 13.26 Cr., marking an increase of 0.50 Cr..
• For OPM %, as of Mar 2025, the value is 39.90%. The value appears to be declining and may need further review. It has decreased from 40.62% (Dec 2024) to 39.90%, marking a decrease of 0.72%.
• For Other Income, as of Mar 2025, the value is 0.98 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Dec 2024) to 0.98 Cr., marking an increase of 0.66 Cr..
• For Interest, as of Mar 2025, the value is 5.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.42 Cr. (Dec 2024) to 5.09 Cr., marking a decrease of 0.33 Cr..
• For Depreciation, as of Mar 2025, the value is 1.87 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.92 Cr. (Dec 2024) to 1.87 Cr., marking a decrease of 0.05 Cr..
• For Profit before tax, as of Mar 2025, the value is 7.28 Cr.. The value appears strong and on an upward trend. It has increased from 5.74 Cr. (Dec 2024) to 7.28 Cr., marking an increase of 1.54 Cr..
• For Tax %, as of Mar 2025, the value is 37.09%. The value appears to be increasing, which may not be favorable. It has increased from 16.03% (Dec 2024) to 37.09%, marking an increase of 21.06%.
• For Net Profit, as of Mar 2025, the value is 4.58 Cr.. The value appears to be declining and may need further review. It has decreased from 4.82 Cr. (Dec 2024) to 4.58 Cr., marking a decrease of 0.24 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.13. The value appears to be declining and may need further review. It has decreased from 2.48 (Dec 2024) to 2.13, marking a decrease of 0.35.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 3:14 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:07 pm

Below is a detailed analysis of the balance sheet data for HB Estate Developers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2024) to 22.00 Cr., marking an increase of 2.00 Cr..
• For Reserves, as of Mar 2025, the value is 153.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2024) to 153.00 Cr., marking an increase of 24.00 Cr..
• For Borrowings, as of Mar 2025, the value is 284.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 311.00 Cr. (Mar 2024) to 284.00 Cr., marking a decrease of 27.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 38.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.00 Cr. (Mar 2024) to 38.00 Cr., marking an increase of 4.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 496.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 494.00 Cr. (Mar 2024) to 496.00 Cr., marking an increase of 2.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 404.00 Cr.. The value appears to be declining and may need further review. It has decreased from 406.00 Cr. (Mar 2024) to 404.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 85.00 Cr. (Mar 2024) to 90.00 Cr., marking an increase of 5.00 Cr..
• For Total Assets, as of Mar 2025, the value is 496.00 Cr.. The value appears strong and on an upward trend. It has increased from 494.00 Cr. (Mar 2024) to 496.00 Cr., marking an increase of 2.00 Cr..

However, the Borrowings (284.00 Cr.) are higher than the Reserves (153.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for HB Estate Developers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has increased from 2.00 (Mar 24) to 5.31, marking an increase of 3.31.
• For Diluted EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has increased from 2.00 (Mar 24) to 5.31, marking an increase of 3.31.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.46. This value is within the healthy range. It has increased from 5.74 (Mar 24) to 8.46, marking an increase of 2.72.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 80.30. It has increased from 75.13 (Mar 24) to 80.30, marking an increase of 5.17.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 80.30. It has increased from 75.13 (Mar 24) to 80.30, marking an increase of 5.17.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 54.15. It has decreased from 55.44 (Mar 24) to 54.15, marking a decrease of 1.29.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 20.90. This value is within the healthy range. It has increased from 20.72 (Mar 24) to 20.90, marking an increase of 0.18.
• For PBIT / Share (Rs.), as of Mar 25, the value is 17.41. This value is within the healthy range. It has increased from 16.95 (Mar 24) to 17.41, marking an increase of 0.46.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.36. This value is within the healthy range. It has increased from 3.71 (Mar 24) to 7.36, marking an increase of 3.65.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.97. This value is within the healthy range. It has increased from 1.97 (Mar 24) to 4.97, marking an increase of 3.00.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.97. This value is within the healthy range. It has increased from 1.97 (Mar 24) to 4.97, marking an increase of 3.00.
• For PBDIT Margin (%), as of Mar 25, the value is 38.60. This value is within the healthy range. It has increased from 37.37 (Mar 24) to 38.60, marking an increase of 1.23.
• For PBIT Margin (%), as of Mar 25, the value is 32.14. This value exceeds the healthy maximum of 20. It has increased from 30.57 (Mar 24) to 32.14, marking an increase of 1.57.
• For PBT Margin (%), as of Mar 25, the value is 13.59. This value is within the healthy range. It has increased from 6.69 (Mar 24) to 13.59, marking an increase of 6.90.
• For Net Profit Margin (%), as of Mar 25, the value is 9.17. This value is within the healthy range. It has increased from 3.55 (Mar 24) to 9.17, marking an increase of 5.62.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.17. This value is within the healthy range. It has increased from 3.55 (Mar 24) to 9.17, marking an increase of 5.62.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 15. It has increased from 2.62 (Mar 24) to 6.18, marking an increase of 3.56.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.84. This value is below the healthy minimum of 10. It has increased from 7.81 (Mar 24) to 8.84, marking an increase of 1.03.
• For Return On Assets (%), as of Mar 25, the value is 2.17. This value is below the healthy minimum of 5. It has increased from 0.78 (Mar 24) to 2.17, marking an increase of 1.39.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.39. This value exceeds the healthy maximum of 1. It has increased from 1.11 (Mar 24) to 1.39, marking an increase of 0.28.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.63. This value exceeds the healthy maximum of 1. It has increased from 1.39 (Mar 24) to 1.63, marking an increase of 0.24.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.23. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1.5. It has increased from 0.60 (Mar 24) to 0.70, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has increased from 0.38 (Mar 24) to 0.49, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.71, marking an increase of 0.71.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.08. This value is below the healthy minimum of 3. It has increased from 1.57 (Mar 24) to 2.08, marking an increase of 0.51.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.49. This value is below the healthy minimum of 3. It has increased from 1.15 (Mar 24) to 1.49, marking an increase of 0.34.
• For Enterprise Value (Cr.), as of Mar 25, the value is 480.62. It has increased from 423.20 (Mar 24) to 480.62, marking an increase of 57.42.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.08. This value exceeds the healthy maximum of 3. It has increased from 3.87 (Mar 24) to 4.08, marking an increase of 0.21.
• For EV / EBITDA (X), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 10.35 (Mar 24) to 10.58, marking an increase of 0.23.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.83, marking an increase of 0.70.
• For Price / BV (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 0.83 (Mar 24) to 1.24, marking an increase of 0.41.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.83, marking an increase of 0.70.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness